Glucotrack (GCTK) Payables (2010 - 2026)

Glucotrack (GCTK) has reported Payables for 17 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables rose 6.2% year-over-year to $2.8 million; the trailing twelve-month figure through Jun 2026 stood at $2.8 million (up 6.2% YoY), and the FY2025 full-year result was $4.5 million, up 351.25% from the prior year.
• Payables slipped to $2.8 million in Q2 2026 per GCTK's latest filing, from $4.5 million in the prior quarter.
• Across five years, Payables topped out at $4.7 million in Q3 2025 and bottomed at $590000.0 in Q1 2022.
• Historically, Payables has averaged $1.7 million across 5 years, with a median of $1.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Payables decreased 15.48% in 2022, then jumped 351.25% in 2025.
• Over 5 years, Payables stood at $672000.0 in 2022, then increased by 24.85% to $839000.0 in 2023, then grew by 18.83% to $997000.0 in 2024, then surged by 351.25% to $4.5 million in 2025, then sank by 37.59% to $2.8 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $2.8 million, $4.5 million, and $4.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.